Caregivers and their patients must agree to participate. The interventions will last 8-10 weeks and study participation will 12 months. Caregivers in all 3 groups (TAU, Virtual-PEPRR, or Pep-Pal) will provide biomarker samples (hair and saliva) that they will collect themselves at home, to maintain social distancing, throughout the year (study start and months 3, 6, 9 and 12). Materials will be mailed to the participants homes with instructions. All participants (caregivers and patients) will also fill out surveys/questionnaires at each of these 5 sample time points ( baseline, m3, m6, m9, m12) that will assess psychological measures (depression, anxiety and stress levels) and employment factors such as status, satisfaction, insurance and accommodations.More
Caregivers: 1) A primary caregiver for a patient with a diagnosis of solid tumor cancer at any stage who are within 8 weeks of starting radiation, infusions, or oral anti-cancer treatment. 2) Spouse or partner of the patient for at least a year and live with patient 3) Must be employed at the time of the patient's diagnosis for a minimum of 20 hours/week with plans to remain employed and working during their patient's adjuvant treatment. Caregivers that were furloughed or laid off due to Covid-19 who are actively looking for work will be included. 4) Ages 18-64 Patients: 1) Patients who have a primary diagnosis of solid tumor cancer at any stage that are within 8 weeks of starting radiation, infusions, or oral anti-cancer treatment. 2) Patient must be spouse or partner of the caregiver for at least a year. 3) 18 years of age or older.
Detailed Eligibility: Exclusion criteria: 1) Having a serious medical condition likely to influence neuroendocrine parameters 2) use of steroid medications 3) if female, pregnant or planning to become pregnant in the next year 4) history of a psychiatric illness unrelated to their experience as a caregiver within the past 18 months.
III - Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.
University of Colorado Hospital
Protocol Number: 20-2458
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers